Literature DB >> 16939857

Plasma serotonin in autism.

Susan L Connors1, Karla J Matteson, Gary A Sega, Carmen B Lozzio, Roger C Carroll, Andrew W Zimmerman.   

Abstract

Serotonin is necessary for normal fetal brain development. Administration of serotonin inhibitors to pregnant rats results in offspring with abnormal behaviors, brain morphology, and serotonin receptor numbers. Low maternal plasma serotonin may contribute to abnormal brain development in autism. In this study, plasma serotonin levels in autism mothers and control mothers of typically developing children were compared, and plasma serotonin levels in children with autism (n = 17) and their family members were measured. Plasma serotonin levels in autism mothers were significantly lower than in mothers of normal children (P = 0.002). Plasma serotonin levels correlated between autism mothers and their children, but differed between autistic children and their fathers (P = 0.028) and siblings (P = 0.063). Low maternal plasma serotonin may be a risk factor for autism through effects on fetal brain development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16939857     DOI: 10.1016/j.pediatrneurol.2006.02.010

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  10 in total

Review 1.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  Brief report: Platelet-poor plasma serotonin in autism.

Authors:  George M Anderson; Margaret E Hertzig; P A McBride
Journal:  J Autism Dev Disord       Date:  2012-07

3.  Peripheral Blood Leukocyte Production of BDNF following Mitogen Stimulation in Early Onset and Regressive Autism.

Authors:  Amanda Enstrom; Charity Onore; Angela Tarver; Irva Hertz-Picciotto; Robin Hansen; Lisa Croen; Judy Van de Water; Paul Ashwood
Journal:  Am J Biochem Biotechnol       Date:  2008

Review 4.  Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder.

Authors:  Valentina R Garbarino; T Lee Gilman; Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Res       Date:  2018-07-24       Impact factor: 7.658

Review 5.  Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD).

Authors:  Tao Xiong; Hongju Chen; Rong Luo; Dezhi Mu
Journal:  Cochrane Database Syst Rev       Date:  2016-10-13

6.  The molecular genetics of autism spectrum disorders: genomic mechanisms, neuroimmunopathology, and clinical implications.

Authors:  Daniel J Guerra
Journal:  Autism Res Treat       Date:  2011-05-17

7.  Reelin Signaling Controls the Preference for Social Novelty in Zebrafish.

Authors:  Elisa Dalla Vecchia; Vincenzo Di Donato; Andrew M J Young; Filippo Del Bene; William H J Norton
Journal:  Front Behav Neurosci       Date:  2019-09-19       Impact factor: 3.558

8.  Autism prevalence in the United States with respect to solar UV-B doses: An ecological study.

Authors:  William B Grant; John J Cannell
Journal:  Dermatoendocrinol       Date:  2013-01-01

Review 9.  Blood platelet research in autism spectrum disorders: In search of biomarkers.

Authors:  Manisha Padmakumar; Eveline Van Raes; Chris Van Geet; Kathleen Freson
Journal:  Res Pract Thromb Haemost       Date:  2019-07-16

Review 10.  Could Candida Overgrowth Be Involved in the Pathophysiology of Autism?

Authors:  Anna Herman; Andrzej Przemysław Herman
Journal:  J Clin Med       Date:  2022-01-15       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.